Journalartikel

Transmissible spongiform encephalopathies - Anesthesiological and intensive care management


AutorenlisteMenges, T; Langefeld, TW; Krumholz, W; Hempelmann, G

Jahr der Veröffentlichung2001

Seiten79-89

ZeitschriftAnästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie

Bandnummer36

Heftnummer2

ISSN0939-2661

DOI Linkhttps://doi.org/10.1055/s-2001-11057

VerlagGeorg Thieme Verlag


Abstract
The transmissible spongiform encephalopathies (TSE) are known to affect humans and various animals. The bovine spongiform encephalopathy (BSE) and the human Creutzfeldt-Jacob disease (CID) are among the most notable degenerative disorders caused by prions. Considering the BSE epidemic and the description of a new variant of Creutzfeldt-Jacob disease (nvCJD), which is probably related to bovine spongiform encephalopathy, TSE have recently gained a lot of public attention. Although the causative factors (prions, viruses) are still under discussion, none of the present concepts are explanatory for all aspects of the human CJD. CJD may present as a sporadic, genetic, or infectious illness and there is now considerable concern that bovine prions may have been passed to humans. To exclude transmission of CJD via medical products and instruments, the effectiveness of cleaning, disinfection and sterilization procedures must be firmly established. This manuscript presents an overview to anaesthesiology and intensive care medicine of recommended inactivation procedures and assessed these procedures in the light of the inactivation of prions.



Zitierstile

Harvard-ZitierstilMenges, T., Langefeld, T., Krumholz, W. and Hempelmann, G. (2001) Transmissible spongiform encephalopathies - Anesthesiological and intensive care management, Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie, 36(2), pp. 79-89. https://doi.org/10.1055/s-2001-11057

APA-ZitierstilMenges, T., Langefeld, T., Krumholz, W., & Hempelmann, G. (2001). Transmissible spongiform encephalopathies - Anesthesiological and intensive care management. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 36(2), 79-89. https://doi.org/10.1055/s-2001-11057



Schlagwörter


bovine spongiform encephalopathy (BSE)BSECREUTZFELDT-JAKOB-DISEASEdisinfection and sterilization proceduresnew variant Creutzfeldt-Jacob disease (nvCJD)Prion proteinScrapietransmissible spongiform encephalopathies (TSE)


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:45